Chandra Bhagat Pharma Chart
Chandra Bhagat Pharma Share Key Metrics
Volume
0.00
Market Cap
25.02 CR
LTQ@LTP
0@33.16
ATP
0
Var Margin
53.5 %
Circuit Range
29.85-36.47
Delivery %
100 %
Value
0.00
ASM/GSM
No
Market Lot
1000
Summary
Chandra Bhagat Pharma Fundamentals
View MoreP/E Ratio
0
P/B Ratio
0
Div. Yield
0
Sector P/E
64.34
Sector P/B
3.51
Sec. Div. Yield
0.57
Chandra Bhagat Pharma Resistance and Support
Pivot 33.16
Resistance
First Resistance
33.16
Second Resistance
33.16
Third Resistance
33.16
Support
First Support
33.16
Second Support
33.16
Third Support
33.16
Chandra Bhagat Pharma Corporate Actions
| Date | Agenda |
|---|---|
| 2025-11-13 | Half Yearly Results |
| 2025-05-29 | Audited Results |
Chandra Bhagat Pharma News
Chandra Bhagat Pharma Ltd - 542934 - Disclosure Under Regulation 30.
Chandra Bhagat Pharma Limited opens a new international representative office in Dubai, UAE. This initiative aims to expand the company's global footprint and enhance export opportunities, with operations expected to commence by March 31, 2026.
Apr 01 2026 15:04:00
About Chandra Bhagat Pharma
NSE : 0
BSE : 542934
ISIN : INE07QQ01016
The Company was incorporated as “Chandra Bhagat Pharma Private Limited” at Mumbai on March 10 2003 under the provisions of the Companies Act 1956 vide Certificate of Incorporation issued by Assistant Registrar of Companies Maharashtra Mumbai. Consequent upon the conversion of our Company from Private Limited Company to Public Limited Company the name of our Company was changed to “Chandra Bhagat Pharma Limited” and fresh Certificate of Incorporation consequent upon the conversion from Private Limited Company to Public Limited Company dated March 20 2019 was issued by the Registrar of Companies RoC – Mumbai. The CIN of the Company is U24230MH2003PLC139534.MAJOR EVENTS2003Incorporation of our company in the name of Chandra Bhagat Pharma Private Limited2015Company has entered into supply and distribution agreement on November 9 2015 with Sinopharm India Private Limited (“Sinopharma”) a subsidiary company of China National Pharmaceutical Group for importing the vaccines known as “HEPATITIS A (HepA).2017Registration for supply of API like Urokinase (Cardiac) L-Asparaginase (Oncology) Heparin Sodium (Nephrology) and Enoxaparin Sodium (Cardiac).2019The Company got converted into Public Limited Company
Chandra Bhagat Pharma Management
| Name | Position |
|---|---|
| Rajni Dawani | Company Secretary & Compliance Officer |
| Hemant Chandravadan Bhagat | Chairman & Managing Director |
Chandra Bhagat Pharma Similar Stocks
NG Industries Ltd.
139.55
0.00 (0.00%)
Shree Pacetronix Ltd.
147.95
0.00 (0.00%)
Vineet Laboratories Ltd.
39.91
0.00 (0.00%)
Centenial Surgical Suture Ltd.
104.50
0.00 (0.00%)
Amkay Products Ltd.
58.30
0.00 (0.00%)
Bandaram Pharma Packtech Ltd.
28.94
0.00 (0.00%)
Mangalam Drugs And Organics Ltd.
28.20
0.00 (0.00%)
Unick Fix-A-Form And Printers Ltd.
39.00
0.00 (0.00%)
Chandra Bhagat Pharma FAQs
